Intravaginal culture using INVOCELL: Is it a viable treatment option for infertility?

Reflections

Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine
Published
Like Comment
Related Content

VOLUME 2, ISSUE 1, P7-8, MARCH 01, 2021

Authors:

Elnur Babayev, M.D., M.Sc., Tarun Jain, M.D.

Abstract:

Reflections on "Real world experience with intravaginal culture using INVOCELL: an alternative model for infertility treatment" by Jellerette-Nolan et al.

Read the full text here. 

Go to the profile of Fertility and Sterility

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. 

Comments

Go to the profile of Saif Ur Rehman
Saif Ur Rehman
3 months ago

Dear Author for the review, what i understand that INVOCell technology is misunderstood by just aiming cost reduction or cost comparison. The major issue around the globe is of huge undeserved infertile population. You stated in your review comments that live birth rates were similar in case of INVOCell, which makes this technology highly relevant, justified and promising for over 95% undeserved infertile population in majority of the countries around the world, which can now be served with relatively low cost set up and resources.